Walgreen (WAG) posted earnings of $683 million, or seventy eight cents per diluted share. Compared with the prior year’s quarter, the mild cough/cold and flu season impacted net earnings per diluted share by three cents, while the effect of no longer being part of the Express Scripts (ESRX) pharmacy provider network as of Jan.